Aviva PLC Haemonetics Corp Transaction History

Aviva PLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 10, 2021	SELL	$51.81 - $118.56 $535,404 - $1.23 Million	-10,334 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$111.01 - $139.48 $507,315 - $637,423	-4,570 Reduced 30.66%	10,334 $1.15 Million
Q4 2020 Feb 10, 2021	SELL	$88.75 - $119.95 $1.07 Million - $1.45 Million	-12,085 Reduced 44.78%	14,904 $1.77 Million
Q3 2020 Nov 12, 2020	BUY	$75.65 - $93.58 $78,222 - $96,761	1,034 Added 3.98%	26,989 $2.36 Million
Q2 2020 Aug 13, 2020	SELL	$84.96 - $118.91 $802,532 - $1.12 Million	-9,446 Reduced 26.68%	25,955 $2.33 Million
Q1 2020 May 14, 2020	BUY	$74.34 - $121.82 $1.46 Million - $2.39 Million	19,648 Added 124.73%	35,401 $3.53 Million
Q4 2019 Feb 10, 2020	BUY	$114.37 - $129.46 $1.8 Million - $2.04 Million	15,753 New	15,753 $1.81 Million

333

53.8M

689K

345K

Ticker HAE
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 51,316,500
Market Cap $3.56B
Description
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...

Get notified when there are updates to the investment portfolio of Aviva PLC, based on Form 13F filings with the SEC.

Stay updated on Aviva PLC with notifications on news.